M M Hitt|F L Graham - JoVE Visualize

Showing results (131-140 of 160) with videos related to

Pageof 16

Sort By:

The Journal of General Virology|October 1, 1993

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infectionJ G Wesseling, G J Godeke, V E Schijns, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999

A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 miceC R Gabaglia, B Pedersen, M Hitt, et al.

Human Gene Therapy|August 14, 1999

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsL Pastore, N Morral, H Zhou, et al.

Journal of Leukocyte Biology|April 1, 1996

Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammationZ Xing, T Braciak, Y Ohkawara, et al.

The Journal of Clinical Investigation|February 1, 1996

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytesM A Morsy, J Z Zhao, T T Ngo, et al.

Journal of Thrombosis and Haemostasis : JTH|January 14, 2004

Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A miceB D Brown, C X Shi, F E M Rawle, et al.

Human Gene Therapy|January 5, 1999

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicityN Morral, R J Parks, H Zhou, et al.

Virology|April 1, 1993

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7scG W Both, L J Lockett, V Janardhana, et al.

Cancer Gene Therapy|July 31, 2001

Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myelomaX Y Wen, S Mandelbaum, Z H Li, et al.

Leukemia|May 23, 2001

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 studyS Trudel, Z Li, C Dodgson, et al.

Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:

Pageof 16

The Journal of General Virology|October 1, 1993

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infectionJ G Wesseling, G J Godeke, V E Schijns, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999

A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 miceC R Gabaglia, B Pedersen, M Hitt, et al.

Human Gene Therapy|August 14, 1999

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsL Pastore, N Morral, H Zhou, et al.

Journal of Leukocyte Biology|April 1, 1996

Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammationZ Xing, T Braciak, Y Ohkawara, et al.

The Journal of Clinical Investigation|February 1, 1996

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytesM A Morsy, J Z Zhao, T T Ngo, et al.

Journal of Thrombosis and Haemostasis : JTH|January 14, 2004

Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A miceB D Brown, C X Shi, F E M Rawle, et al.

Human Gene Therapy|January 5, 1999

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicityN Morral, R J Parks, H Zhou, et al.

Virology|April 1, 1993

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7scG W Both, L J Lockett, V Janardhana, et al.

Cancer Gene Therapy|July 31, 2001

Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myelomaX Y Wen, S Mandelbaum, Z H Li, et al.

Leukemia|May 23, 2001

Adenovector engineered interleukin-2 expressing autologous plasma cell vaccination after high-dose chemotherapy for multiple myeloma--a phase 1 studyS Trudel, Z Li, C Dodgson, et al.

Pageof 16